These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 21176017)
1. Early post-transplant vaccination with pandemic influenza A/H1N1 vaccine in pediatric heart transplant recipients. Altamirano-Diaz L; West L; Humar A; Ely L; Urschel S; Gubbay J; Crowcroft N; Kumar D Pediatr Transplant; 2011 Mar; 15(2):172-5. PubMed ID: 21176017 [TBL] [Abstract][Full Text] [Related]
2. Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination. Lagler H; Wenisch JM; Tobudic S; Gualdoni GA; Rödler S; Rasoul-Rockenschaub S; Jaksch P; Redlberger-Fritz M; Popow-Kraupp T; Burgmann H Vaccine; 2011 Sep; 29(40):6888-93. PubMed ID: 21803100 [TBL] [Abstract][Full Text] [Related]
3. The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic. Engelhard D; Zakay-Rones Z; Shapira MY; Resnick I; Averbuch D; Grisariu S; Dray L; Djian E; Strauss-Liviatan N; Grotto I; Wolf DG; Or R Vaccine; 2011 Feb; 29(9):1777-82. PubMed ID: 21216315 [TBL] [Abstract][Full Text] [Related]
4. Immune response to pandemic H1N1 2009 influenza a vaccination in pediatric liver transplant recipients. Haller W; Buttery J; Laurie K; Beyerle K; Hardikar W; Alex G Liver Transpl; 2011 Aug; 17(8):914-20. PubMed ID: 21351241 [TBL] [Abstract][Full Text] [Related]
5. Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients. Meyer S; Adam M; Schweiger B; Ilchmann C; Eulenburg C; Sattinger E; Runte H; Schlüter M; Deuse T; Reichenspurner H; Costard-Jäckle A Transplantation; 2011 May; 91(9):1031-5. PubMed ID: 21358365 [TBL] [Abstract][Full Text] [Related]
6. Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months. Esposito S; Pugni L; Daleno C; Ronchi A; Valzano A; Serra D; Mosca F; Principi N Pediatrics; 2011 May; 127(5):e1161-8. PubMed ID: 21464195 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of inactivated 2009 H1N1 influenza vaccine in pediatric liver transplant recipients. Torii Y; Kimura H; Ochi N; Kaneko K; Ando H; Kiuchi T; Ito Y Vaccine; 2011 Jun; 29(25):4187-9. PubMed ID: 21513762 [TBL] [Abstract][Full Text] [Related]
9. Immune response to 2009 pandemic H1N1 influenza virus A monovalent vaccine in children with cancer. Yen TY; Jou ST; Yang YL; Chang HH; Lu MY; Lin DT; Lin KH; Huang LM; Chang LY Pediatr Blood Cancer; 2011 Dec; 57(7):1154-8. PubMed ID: 21425448 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10. Emborg HD; Krause TG; Hviid A; Simonsen J; Mølbak K BMJ; 2011 Jan; 344():d7901. PubMed ID: 22277542 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in children. Gilca R; Deceuninck G; De Serres G; Boulianne N; Sauvageau C; Quach C; Boucher FD; Skowronski DM Pediatrics; 2011 Nov; 128(5):e1084-91. PubMed ID: 21987710 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents. Lu CY; Shao PL; Chang LY; Huang YC; Chiu CH; Hsieh YC; Lin TY; Huang LM Vaccine; 2010 Aug; 28(36):5864-70. PubMed ID: 20600484 [TBL] [Abstract][Full Text] [Related]
13. Effect of two injections of non-adjuvanted influenza A H1N1pdm2009 vaccine in renal transplant recipients: INSERM C09-32 TRANSFLUVAC trial. Le Corre N; Thibault F; Pouteil Noble C; Meiffrédy V; Daoud S; Cahen R; Charreau I; Bottigioli D; Dollinger C; Aboulker JP; Autran B; Morelon E; Barrou B Vaccine; 2012 Dec; 30(52):7522-8. PubMed ID: 23103195 [TBL] [Abstract][Full Text] [Related]
14. Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients. Fairhead T; Hendren E; Tinckam K; Rose C; Sherlock CH; Shi L; Crowcroft NS; Gubbay JB; Landsberg D; Knoll G; Gill J; Kumar D Transpl Infect Dis; 2012 Dec; 14(6):575-83. PubMed ID: 22999005 [TBL] [Abstract][Full Text] [Related]
15. Pandemic 2009 H1N1 influenza virus vaccination in lung transplant recipients: coverage, safety and clinical effectiveness in the Zurich cohort. Schuurmans MM; Tini GM; Dalar L; Fretz G; Benden C; Boehler A J Heart Lung Transplant; 2011 Jun; 30(6):685-90. PubMed ID: 21444211 [TBL] [Abstract][Full Text] [Related]
16. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948 [TBL] [Abstract][Full Text] [Related]
17. Influenza A (H1N1) 2009 two-dose immunization of US children: an observer-blinded, randomized, placebo-controlled trial. Plennevaux E; Blatter M; Cornish MJ; Go K; Kirby D; Wali M; Reeves-Hoché MK; Denis M Vaccine; 2011 Feb; 29(8):1569-75. PubMed ID: 21219979 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults. Hakim H; Allison KJ; Van De Velde LA; Li Y; Flynn PM; McCullers JA Vaccine; 2012 Jan; 30(5):879-85. PubMed ID: 22155630 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children. Phongsamart W; Sirisanthana V; Wittawatmongkol O; Maleesatharn A; Sudjaritruk T; Chearskul P; Aurpibul L; Sirisanthana T; Chokephaibulkit K Vaccine; 2011 Nov; 29(47):8705-11. PubMed ID: 21893147 [TBL] [Abstract][Full Text] [Related]